Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ).
Sinco Pharmaceuticals Holdings Ltd. has announced its upcoming annual general meeting scheduled for May 15, 2025, in Kunming City, China. Key agenda items include the adoption of the 2024 financial statements, re-election of directors, re-appointment of auditors, and approval of a final dividend. These resolutions are expected to impact the company’s governance and financial strategies, potentially influencing shareholder value and market perception.
More about Sinco Pharmaceuticals Holdings Ltd.
Sinco Pharmaceuticals Holdings Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is incorporated under the laws of the Cayman Islands and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -10.50%
Average Trading Volume: 540,071
Technical Sentiment Signal: Buy
Current Market Cap: HK$363.9M
See more insights into 6833 stock on TipRanks’ Stock Analysis page.